The KEEPsAKE 1 trial is a phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of risankizumab, a biological therapy targeting interleukin 23, in patients with active psoriatic arthritis (PsA) who have had inadequate responses or intolerance to conventional synthetic disease-modifying antirheumati
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes
Catheter Ablation for Atrial Fibrillation with HF
691 Reached
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments
Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes